Clinical Research

Real Data. Real Impact.

Valor-Humani First clinical trials

Published by: Dr. Farkhod Raufov & Amir Tivon IMNA

Dr. Farkhod Raufov, from the “samarkand branch of republican specialized scientific and practical medical center of oncology and radiology” in Uzbekistan- samarkand and Amir Tivon IMNA

Report on Comparative Analysis Between Treatment and Control Groups

Published by: Dr. Raufov F.M.

Report on Comparative Analysis Between Treatment and Control Groups 1. Blood Test Conditions.Based on the available data, the control group exhibited worse overall blood test conditions compared to the treatment

Clinical Trials Overall Report

Published by: Dr. Raufov F.M.

Short summary: Primary conclusion of investigators.

Valor Humani: An Integrative Approach to Cancer Care

Published by: A White Paper on Clinical Observations, Research, and Case Studies

Executive Summary Valor Humani is a natural, integrative therapy derived from plant extracts, designed to complement conventional cancer treatments. Pre-clinical research has demonstrated its ability to selectively target cancer cells

Clinical Insights: Valor Humani in Gastrointestinal Cancers

Published by: Dr. Farhat Raoufouf

A two-year clinical investigation in Uzbekistan evaluated Valor Humani as supportive therapy for gastrointestinal cancers. Patients combining it with chemotherapy showed fewer side effects, improved appetite, and better quality of

Valor Humani in Gastrointestinal and Other Cancers

Published by: Amir Tivon

Pre-clinical research on aggressive colon cancer cells showed Valor Humani triggered autosis, leading to cancer cell death while sparing healthy cells. Clinical observations extend to gastrointestinal, breast, liver, and blood

Lymphoma Care: A Case Study

Published by: Amir Tivon

Valor Humani was applied in a patient with aggressive lymphoma presenting severe wounds near the neck. Over eight months of treatment, the lesions healed completely, pain subsided, and quality of

From Laboratory Research to International Clinical Applications

Published by: Amir Tivon

Laboratory tests on pancreatic ASPC-1 cells revealed a 70% reduction in cancer cells after 48 hours, with no harm to healthy cells. Clinical experiences include a glioblastoma patient whose tumor

Insights from Gastrointestinal and Other Cancers

Published by: Amir Tivon

Pre-clinical studies on colon cancer cells demonstrated Valor Humani’s ability to trigger autosis, a process of cancer cell self-destruction, while sparing healthy cells. Applied in gastrointestinal, breast, liver, and hematological

A Case Study in Lymphoma Care

Published by: Amir Tivon

Valor Humani, an integrative therapy, was applied in a complex lymphoma case with visible lesions near the neck. Over eight months, the patient experienced progressive wound healing, pain reduction, and

Website by TalPress